Rheumatology Flashcards

1
Q

Polymyalgia rheumatica features

A

There is no true weakness of limb girdles in polymyalgia rheumatica on examination. Any weakness of muscles is due to myalgia (pain inhibition).

ESR elevated. CK normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Imaging to support diagnosis of ankylosing spondylitis?

A

sacro-ilitis on a pelvic X-ray

well formed syndesmophytes on lumbar spine film (ossification of outer fibres of annulus fibrosus)

subchondral erosions, sclerosis
and squaring of lumbar vertebrae on X-ray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for pseudo gout?

A
increasing age
haemochromatosis
hyperparathyroidism
low magnesium, low phosphate
acromegaly, Wilson's disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of temporal arteritis?

A

urgent high-dose glucocorticoids should be given as soon as the diagnosis is suspected and before the temporal artery biopsy

if there is no visual loss then high-dose prednisolone is used

if there is evolving visual loss IV methylprednisolone is usually given prior to starting high-dose prednisolone

there should be a dramatic response, if not the diagnosis should be reconsidered

if visual symptoms, then same day review by opthamologist

bone protection with bisphosphonates is required as long, tapering course of steroids is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lateral epicondylitis on examination

A

worse on resisted wrist extension/suppination whilst elbow extended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to distinguish pseudo gout from gout?

A

Crystals - Gout is caused by sodium urate crystals and pseudogout is caused by calcium pyrophosphate crystals.

X-ray - Chondrocalcinosis helps to distinguish pseudogout from gout

Joints affected - Gout most commonly affects the big toe, instep, heel, ankle, and/or knee. Pseudogout is most likely to affect the knee, wrist, and/or large knuckles of the hand (metacarpophalangeal joints). It may also involve the hip, shoulder, and/or spine

Severity, timing, duration of pain - Gout more severe than pseudo gout. Gout often strikes in middle of night, pseudo gout can strike at any time. If left untreated, gout attack symptoms will usually go away within a few days or weeks. Left untreated, an episode of pseudogout can last days, weeks, or even months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of drug-induced lupus?

A

Most common causes
procainamide
hydralazine

Less common causes
isoniazid
minocycline
phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibodies in drug induced lupus?

A

ANA positive in 100%, dsDNA negative
anti-histone antibodies are found in 80-90%
anti-Ro, anti-Smith positive in around 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Features of drug induced lupus?

A

arthralgia
myalgia
skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antibodies in Sjogren’s syndrome?

A

rheumatoid factor (RF) positive in nearly 50% of patients
ANA positive in 70%
anti-Ro (SSA) antibodies in 70% of patients with PSS
anti-La (SSB) antibodies in 30% of patients with PSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Features of Sjogren’s syndrome?

A
dry eyes: keratoconjunctivitis sicca
dry mouth
vaginal dryness
arthralgia
Raynaud's, myalgia
sensory polyneuropathy
recurrent episodes of parotitis
renal tubular acidosis (usually subclinical)

marked increased risk of lymphoid malignancy (40-60 fold).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of Sjogren’s syndrome?

A

artificial saliva and tears

pilocarpine may stimulate saliva production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations of Sjogren’s syndrome?

A

auto-antibodies
Schirmer’s test: filter paper near conjunctival sac to measure tear formation
histology: focal lymphocytic infiltration
also: hypergammaglobulinaemia, low C4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Felty’s syndrome?

A

a condition characterized by splenomegaly and neutropenia in a patient with rheumatoid arthritis. Hypersplenism results in destruction of blood cells which classically results in neutropenia but can also cause pancytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presentation of psoriatic arthritis?

A

seronegative spondyloarthropathies. It correlates poorly with cutaneous psoriasis and often precedes the development of skin lesions.
males and females being equally affected
HLA-B27

Patterns:
symmetric polyarthritis
asymmetrical oligoarthritis: typically affects hands and feet
sacroilitis
DIP joint disease
arthritis mutilans 

Other signs
psoriatic skin lesions
periarticular disease - tenosynovitis and soft tissue inflammation resulting in:
enthesitis: inflammation at the site of tendon and ligament insertion e.g. Achilles tendonitis, plantar fascitis
tenosynovitis: typically of the flexor tendons of the hands
dactylitis: diffuse swelling of a finger or toe ‘sausage fingers’
nail changes
pitting
onycholysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

X-ray of psoriatic arthropathy?

A

often have the unusual combination of coexistence of erosive changes and new bone formation
periostitis
‘pencil-in-cup’ appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Management of psoriatic arthropathy?

A

should be managed by a rheumatologist
treatment is similar to that of rheumatoid arthritis (RA). However, the following differences are noted:
mild peripheral arthritis/mild axial disease may be treated with ‘just’ an NSAID, rather than all patients being on disease-modifying therapy as with RA
use of monoclonal antibodies such as ustekinumab (targets both IL-12 and IL-23) and secukinumab (targets IL-17)
has a better prognosis than RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pattern of pyrexia in Still’s disease?

A

it typically rises in the late afternoon/early evening in a daily pattern and accompanies a worsening of joint symptoms and rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Malignancy + raised CK?

A

Think about polymyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Features of ankylosing spondylitis? 6 A’s

A
  • Apical fibrosis
  • Anterior uveitis
  • Aortic regurgitation
  • Achilles tendonitis
  • AV node block
  • Amyloidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anti-phospholipid syndrome presentation

A

CLOTS: clots, livedo reticularis, obstetric complications and thrombocytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cause of Marfan’s syndrome?

A

caused by a mutation in a protein called fibrillin-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Bone pain, tenderness and proximal myopathy (→ waddling gait)?

A

Osteomalacia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is Behcet’s syndrome?

A

is a complex multisystem disorder associated with presumed autoimmune-mediated inflammation of the arteries and veins.

Features

  • classically: 1) oral ulcers 2) genital ulcers 3) anterior uveitis
  • thrombophlebitis and deep vein thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What antibody can help assist in making diagnosis of anti-phospholipid syndrome?

A

a positive anti-Cardiolipin antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is dermatomyositis?

A

is usually an autoimmune condition, being most common in women aged 50-70. However, it can also be a paraneoplastic disease, with ovarian, breast and lung tumours being the most common underlying cancers. The possibility of underlying malignancy should be considered, especially in older patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Why are chemotherapy patients at an increased risk of gout?

A

from increased urate production. Cytotoxic drugs cause an increase in the breakdown of cells, releasing products that are degraded into uric acid. Hyperuricaemia is a known risk factor for gout.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is osteoarthritis?

A

It is a chronic, degenerative disease affecting large weight bearing joints. It is clinically diagnosed, but X-ray changes can support diagnosis if needed.

Caused by ‘wear and tear’, so localised loss of cartilage, remodelling of adjacent bone and associated inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is typical OA history?

A

Chronic history of pain in large bearing joints (knee, hips)
Worsened by exercise, and relieved by rest
Has morning stiffness, lasting less than 30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Risk factors for OA?

A

non-modifiable = age, gender (female), previous trauma/hypermobility

modifiable = obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Management of OA

A
  • Modifiable risk factors - lifestyle
    - Medical
    - Simple analgesia - paracetamol and topical NSAID (only in knee/hand)
    - Oral NSAIDs (+ PPI cover), opioids, capsaicin cream and intra articular (joint) steroid injections
    - Surgical
    - Last resort - arthroplasty
    - Post op physio and exercise, walking aid needed for 6-8 weeks
    - Can impact QoL - can’t flex hip, sit in low chairs, cross legs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Hand signs of OA

A
  • signs seen in hands earlier than larger joints
  • painless nodes
  • Bouchard in PIP
  • Heberdens in DIP
  • squaring of thumbs - due to fixed adduction of thumb
  • x-ray changes come before Sx, and are not linked to functional dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is Rheumatoid arthritis?

A
  • Chronic inflammatory, autoimmune, synovial joint inflammation, causing intra and peri articular joint dysfunction
  • Additionally has extra articular, systemic features

Common in young middle aged woman with bilateral hand pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Risk factors for RA?

A
modifiable = smoking, obesity
non-modifiable = female, FHX, age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Typical features of RA?

A
  • Swollen painful joints in bilateral hands
    - Stiffness worse in morning >30 mins, better with use
    - Insidious onset that gets worse
    - Systemic involvement - fatigue, fevers, WL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How to diagnose RA?

A
  • Initial investigations
    - RF (IgM) - sensitive not specific
    - Anti CCP - more specific
    - x-rays:
    - Loss of joint space
    - Erosions
    - Soft tissue swelling
    - Soft bones (osteopenia)
    - 2010 ACOR criteria:
    - Joint involvement
    - Serology
    - Acute phase reactants (CRP/ESR)
    - Duration of Sx (6wk)
    - Scored /10, 6 = RA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are poor prognostic factors for RA?

A
  • Positive serology
    - RF
    - Anti CCP
    - HLA DR4
    - Poor function at presentation
    - X-ray changes, e.g., early erosions
    - Extra articular features
    - Insidious onset
  • development of CVD is main cause of death in these patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How to assess prognosis of RA?

A
  • DAS28 - measure of disease activity and response to Tx in RA
    - HAQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Hand signs in RA?

A
  • Ulnar deviation - subluxation of MCP joint
    - Boutonniere - PIP flexion with DIP extension
    - Swan neck - PIP extension with DIP flexion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Management of RA?

A

1 - monotherapy with methotrexate, leflunomide or sulfalazine. mild cases treated with hydroxychloroquine
2 - dual therapy
3 - methotrexate + biologic (TNFa)
4 - methotrexate + rituximab

remission is induced with corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Use of methotrexate in RA?

A
  • is a folate antagonist - taken once a week with folate other days
  • start - FBC, renal and LFT, then weekly until stabilised, then every 2-3 months
  • SFx - liver and lung fibrosis, anaemia, myelosuppression, mouth ulcer (most common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Use of hydroxycloroquine in RA?

A
  • antimalarial
  • can be used in pregnant women
  • SFx - nightmares, skin pigmentation, macular damage (bullseye retinopathy)
  • monitor - ask about visual Sx and test visual acuity annually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Use of sulfasalazine in RA?

A
  • pro drug for 5-ASA, decreases neutrophil chemotaxis and suppresses proliferation of lymphocytes and cytokines
  • cautions - G6PD deficiency, allergy to aspirin and sulphonamides
  • Adverse effects - oliospermia, SJS, pneumonitis/lung fibrosis, myelosuppresion, Heinz body anaemia, megaloblastic anaemia, may colour tears
  • safe in pregnancy and breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Use of Leflunomide in RA?

A
  • DMARD

- SFx - HTN, rash, peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Use of anti TNF (etanercept, infliximab, adalimumab) in RA?

A
  • susceptible to sepsis

- need CXR - can reactivate TB

46
Q

Extra-articular signs of RA?

A

Cardiovascular: CAD, atherosclerosis, pericarditis, rheumatoid vasculitis, Raynaud’s

GI: oesophagitis, gastritis, ulcer disease, hepatotoxicity, Felty’s syndrome

Skin: vascular lesions, rheumatoid nodules

Neurological: cervical myelopathy, peripheral neuropathy, mononeuritis multiplex, entrapment neuropathy

Ocular: keratoconjunctivitis sicca, episcleritis, sclerisi, scleromalacia perforans

Renal: tubulo-interstitial nephritis, amyloidosis, membranous glomerulonephritis

Pulmonary: interstitial lung disease, pleural disease (including effusion), bronchiolitis obliterates, amyloidosis, Caplan’s syndrome, bronchiectasis, drug toxicity

Haematological: anaemia, thrombocytosis, Felty’s syndrome

47
Q

Most common need for revision of a hip replacement

A

Aseptic loosening of the joint

48
Q

Posterior dislocation in a hip replacement?

A

Due to extreme hip flexion, causes painful clunk and short IR leg

49
Q

What is ankylosing spondylitis?

A

Ankylosing spondylitis is a HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.

50
Q

Features of ankylosing spondylitis?

A

typically a young man who presents with lower back pain and stiffness of insidious onset

stiffness is usually worse in the morning and improves with exercise

the patient may experience pain at night which improves on getting up

51
Q

Associated features of ankylosing spondylitis? (6 A’s)

A
anterior uveitis
apical fibrosis
AV block 
aortic regurgitation
achilles tendonitis
amyloidosis
52
Q

Examination findings of ankylosing spondylitis?

A

reduced lateral flexion
reduced forward flexion - Schober’s test - a line is drawn 10 cm above and 5 cm below the back dimples (dimples of Venus). The distance between the two lines should increase by more than 5 cm when the patient bends as far forward as possible
reduced chest expansion

53
Q

X-ray changes seen in ankylosing spondylitis?

A

sacroiliitis: subchondral erosions, sclerosis
squaring of lumbar vertebrae
‘bamboo spine’ (late & uncommon)
syndesmophytes: due to ossification of outer fibers of annulus fibrosus
chest x-ray: apical fibrosis

if no changes and high suspicion for AS - MRI, may show early signs of inflammation (bone marrow oedema)

additional spirometry -may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis and ankylosis of the costovertebral joints.

54
Q

Management of ankylosing spondylitis?

A

encourage regular exercise such as swimming
NSAIDs are the first-line treatment
physiotherapy

the disease-modifying drugs which are used to treat rheumatoid arthritis (such as sulphasalazine) are only really useful if there is peripheral joint involvement

the 2010 EULAR guidelines suggest: ‘Anti-TNF therapy (etanercept) should be given to patients with persistently high disease activity despite conventional treatments’

55
Q

What is psoriatic arthritis?

A

Psoriatic arthropathy is an inflammatory arthritis associated with psoriasis and is classed as one of the seronegative spondyloarthropathies.

It correlates poorly with cutaneous psoriasis and often precedes the development of skin lesions.

Around 10-20% of patients with skin lesions develop an arthropathy with males and females being equally affected.

56
Q

Presentation patterns of psoriatic arthritis?

A

symmetric polyarthritis-
very similar to rheumatoid arthritis
30-40% of cases, most common type

asymmetrical oligoarthritis: typically affects hands and feet (20-30%)
until recently it was thought asymmetrical oligoarthritis was the most common type

DIP joint disease (10%)

arthritis mutilans (severe deformity fingers/hand, ‘telescoping fingers’)

57
Q

Presentation of psoriatic arthritis?

A

psoriatic skin lesions

periarticular disease -
tenosynovitis and soft tissue inflammation resulting in:
enthesitis: inflammation at the site of tendon and ligament insertion e.g. Achilles tendonitis, plantar fascitis
tenosynovitis: typically of the flexor tendons of the hands

dactylitis: diffuse swelling of a finger or toe

nail changes = pitting,
onycholysis

58
Q

X-ray changes seen in psoriatic arthritis?

A

often have the unusual combination of coexistence of erosive changes and new bone formation
periostitis
‘pencil-in-cup’ appearance

59
Q

Management of psoriatic arthritis?

A

should be managed by a rheumatologist
treatment is similar to that of rheumatoid arthritis (RA). However, the following differences are noted:
mild peripheral arthritis/mild axial disease may be treated with ‘just’ an NSAID, rather than all patients being on disease-modifying therapy as with RA
use of monoclonal antibodies such as ustekinumab (targets both IL-12 and IL-23) and secukinumab (targets IL-17)
has a better prognosis than RA

60
Q

What is reactive arthritis?

A

HLA-B27 associated seronegative spondyloarthropathies

classic triad of urethritis, conjunctivitis and arthritis

an arthritis that develops following an infection where the organism cannot be recovered from the joint.

61
Q

Features of reactive arthritis?

A

4 wks to occur, lasts 4-6 month

‘can’t see, pee or climb a tree’ - uveitis, balanitis, arthritis

asymmetrical oligoarthritis of lower limbs

dactylitis

eye - conjunctivitis, anterior uveitis

skin - circinate balanitis (painless vesicles on coronal margin of prepuce), Keratoderma blenorrhagina

post-dystenteric - Shigella, salmonella, yersinia, campylobacter

post-STI - chlamydia

62
Q

Management of reactive arthritis?

A

symptomatic: analgesia, NSAIDS, intra-articular steroids

sulfasalazine and methotrexate are sometimes used for persistent disease

symptoms rarely last more than 12 months

63
Q

What is gout?

A

a form of inflammatory arthritis caused by extra uric acid in the body, causing crystals and macrophages in joints then causing swelling and pain

64
Q

Features of gout?

A

episodes lasting several days when their gout flares and are often symptom-free between episodes. episodes develop maximal intensity within 12 hours.

pain, swelling, erythema

70% of first presentations affect 1st MTP joint. other common joints include: ankle, wrist, knee

65
Q

Typical patients with gout?

A

Elderly, overweight, with other co-morbidities

66
Q

Risk factors for gout?

A
Non-modifiable:
age
male
Hx of it
kidney disease
Modifiable:
weight
dietary intake - alcohol, red meats, fish
smoking
drugs - diuretics - loop and thiazides
67
Q

Management of acute gout?

A

NSAIDs or colchicine first line

max dose of NSAID prescribed 1-2 days after Sx settled. PPI may be required

colchicine - inhibits microtubule polymerisation - slow onset, diarrhoea

oral steroids if NSAIDs and colchicine contraindicated

allopurinol continued if already taking

68
Q

Indications for rate-lowering therapy

A

now for all patients after first attack of gout

ULT is particularly recommended if:
>= 2 attacks in 12 months
tophi
renal disease
uric acid renal stones
prophylaxis if on cytotoxics or diuretics
69
Q

Prophylaxis of gout?

A

allopurinol is first-line - delay in starting after acute attack. Has SFx of myelosuppression with azathioprine

100mg od, with dose titrated every few weeks to aim for serum uric acid of <300 mol/l

colchicine (or NSAID if CI’d) cover when starting allopurinol - may need to continue for 6m

second-line - febuxostat

lifestyle modifications

  • reduce alcohol intake
  • lose weight if obese
  • avoid food high in purines - liver, kidney, seafood, oily fish, yeast products
70
Q

Findings of gout on synovial fluid analysis?

A

needle shaped negatively birefringent monosodium urate crystals under polarised light

71
Q

Gout vs pseudogout?

A

Gout = uric acid = needle shaped negative light
Pseudo gout = calcium = rhomboid shaped positive

Pseudogout associated with:

  • haemochromatosis
  • high calcium - acromegaly
  • Wilson’s

Pseudogout on X-ray - linear calcification on knee

72
Q

What is pseudo gout?

A

form of microcrystal synovitis caused by the deposition of calcium pyrophosphate dihydrate crystals in the synovium.

associated with increasing age. if younger age have underlying risk factor: haemochromatosis, Hyperparathyroidism, low Mg, low phosphate, acromegaly, Wilsons

Features - knee, wrist and shoulders most commonly

Management - aspiration of joint fluid to exclude SA, NSAIDs or intra-articular, IM or oral steroids as for gout

73
Q

Differentials for RA?

A

RA
SLE
Psoriatic arthritis

74
Q

What is septic arthritis?

A

an infection in the joint (synovial) fluid and joint tissues.

It occurs more often in children than in adults.

The infection usually reaches the joints through the bloodstream. In some cases, joints may become infected due to an injection, surgery, or injury.

75
Q

Pathophysiology of septic arthritis?

A

most common organism overall is Staphylococcus aureus

in young adults who are sexually active, Neisseria gonorrhoeae

most common cause is haematogenous spread - may be from distant bacterial infections (e.g., abscesses)

most common location is knee

76
Q

Features of septic arthritis?

A

acute, swollen joint
restricted movement

examination findings: warm to touch/fluctuant

fever: present in the majority of patients

in children, more common in boys (2:1), joints affected are hip, knee and ankle

77
Q

Investigations for septic arthritis?

A

Synovial fluid sampling (prior to Abx administration if necessary)

Blood cultures

Joint imaging

78
Q

Management of septic arthritis?

A

Sepsis 6, senior help, supportive care as needed

intravenous antibiotics which cover Gram-positive cocci are indicated. The BNF currently recommends flucloxacillin or clindamycin if penicillin allergic

Abx Tx normally given for 4-6 wks, switched to oral Abx after 2 wks

needle aspiration used to decompress the joint

arthroscopic lavage may be required

79
Q

Kocher’s criteria for diagnosis of septic arthritis in children?

A

fever >38.5 degrees C
non-weight bearing
raised ESR
raised WCC

80
Q

Management of anti phospholipid?

A

No VTE - aspirin

1 VTE - lifelong warfarin - INR 2-3

Multiple - INR 3-4

Arterial thrombosis - INR 2-3

81
Q

Typical features of Marfan’s?

A

Tall pt’s with long arms and fingers

Hypermobility

Pectus craniartum/ excavatum

Scoliosis

High-arched palate

Pes Planus

Dilation of aortic sinuses > aortic aneurysms, aortic dissection, aortic regurgitation, MV prolapse

82
Q

Gene mutations in Marfan’s?

A

Autosomal dominant

Defect in protein fibrillin 1

83
Q

Common complications in Marfan’s?

A

Pneumothorax

MV prolapse

AV prolapse

Aortic aneurysm

84
Q

Management of Marfan’s?

A

Regular ECHO monitoring

Beta-blockers

ACEi

Genetic counselling

Avoid intense exercise and caffeine

85
Q

Prognosis of Marfan’s?

A

Used to be 50 yrs, but this has increased

Aortic dissection most common cause of death

86
Q

Typical features of Ehlers Danlos

A

Joint hyper motility

Stretchy, fragile skin

87
Q

Gene mutations of EDS

A

Collagen defects - mostly type III collagen

Mainly autosomal dominant

Hypermobilie variant is not AD

88
Q

Common complications of EDS

A

Postural orthostatic tachycardia syndrome (POTS) - autonomic dysfunction

Joint problems - arthritis, pains, dislocation etc.

Skin problems - cuts, poor healing, bruising

AR regurgitation, MV prolapse, aortic dissection

SAH

Angioid retinal streaks

89
Q

Management of EDS?

A

No cure

Manage Sx and complications

90
Q

Prognosis of EDS?

A

Beighton score diagnosis (out of 9)

Palms flat, hyperextension (elbow, knee, pinky)

Thumb to forearm

91
Q

What is systemic lupus erythematosus (SLE)?

A

a chronic disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels, which provide strength and flexibility to structures throughout the body.

The signs and symptoms of SLE vary among affected individuals, and can involve many organs and systems, including the skin, joints, kidneys, lungs, central nervous system, and blood-forming (hematopoietic) system.

Autoimmune

Type 3 hypersensitivity reaction (immune complex deposition)

associated with HLA B8, DR2, DR3

92
Q

Epidemiology of SLE?

A

F>M (9:1)

more common in Afro-Caribbean and Asian

onset 20-40 yrs

incidence has risen substantially in past 50 yrs

93
Q

Common exam presentation of SLE?

A

young/middle aged female presenting with a photosensitive face rash, fatigue/malaise and possible joint pains

94
Q

Features of SLE?

A
General features
fatigue
fever
mouth ulcers
lymphadenopathy

Skin
malar (butterfly) rash: spares nasolabial folds
discoid rash: scaly, erythematous, well demarcated rash in sun-exposed areas. Lesions may progress to become pigmented and hyperkeratotic before becoming atrophic
photosensitivity
Raynaud’s phenomenon
livedo reticularis
non-scarring alopecia

Musculoskeletal
arthralgia
non-erosive arthritis

Cardiovascular
pericarditis: the most common cardiac manifestation
myocarditis

Respiratory
pleurisy
fibrosing alveolitis

Renal
proteinuria
glomerulonephritis (diffuse proliferative glomerulonephritis is the most common type)

Neuropsychiatric
anxiety and depression
psychosis
seizures

95
Q

Investigations of SLE?

A

99% pt’s are ANA positive

20% RF positive

anti-dsDNA - highly specific, but less sensitive

anti-Smith - highly specific, sensitivity (30%)

Also - anti-U1 RNP, SS-A, and SS-B

96
Q

Monitoring of SLE?

A

inflammatory markers:
ESR is generally used

during active disease the CRP may be normal - a raised CRP may indicate underlying infection

complement levels (C3, C4) are low during active disease (formation of complexes leads to consumption of complement)

anti-dsDNA titres can be used for disease monitoring (but note not present in all patients)

97
Q

Management of SLE?

A

NSAIDs
sun-block

Hydroxychloroquine - the treatment of choice for SLE

If internal organ involvement e.g. renal, neuro, eye then consider prednisolone, cyclophosphamide

98
Q

What antibodies are in drug-induced lupus?

A

Anti-histone antibodies

ANA positive in 100%

dsDNA negative

99
Q

Causes of drug-induced lupus?

A

Most common causes
procainamide
hydralazine

Less common causes
isoniazid
minocycline
phenytoin

causes: arthralgia, myalgia, malar rash, pulmonary involvement (e.g., pleurisy)

100
Q

What is limited cutaneous systemic sclerosis?

A

Raynaud’s may be first sign

Scleroderma affects face and distal limbs predominately

Associated with anti-centromere antibodies

A subtype of limited systemic sclerosis is CREST syndrome: Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia

101
Q

What is diffuse cutaneous systemic sclerosis?

A

Scleroderma affects trunk and proximal limbs predominately

Associated with scl-70 antibodies

CREST + internal organ disease such as CVD, HTN< pulmonary fibrosis, glomerulonephritis

The most common cause of death is now respiratory involvement, which is seen in around 80%: interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH)

Anti-Scl 70 antibodies

Other complications include renal disease and hypertension

Poor prognosis

102
Q

What is Sjogren’s syndrome?

A

an autoimmune disorder affecting exocrine glands resulting in dry mucosal surfaces.

It may be primary (PSS) or secondary to rheumatoid arthritis or other connective tissue disorders, where it usually develops around 10 years after the initial onset.

Sjogren’s syndrome is much more common in females (ratio 9:1).

There is a marked increased risk of lymphoid malignancy (40-60 fold)

Schirmer’s test - filter paper near conjunctival sac to measure tear formation

Anti-Ro and Anti-La antibodies

Hypergammaglobulinaemia, low C4

Management - artificial saliva and tears, pilocarpine to stimulate salvia production

103
Q

What is myositis and dermatomyositis?

A

inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions

dermatomyositis often indicates malignancy (ovarian, breast, lung)

Gottron’s papules - roughened red papules over extensor surfaces of fingers

Elevated CK

Myositis - anti-Jo 1
Dermatomyositis - anti-Jo 2

104
Q

What is anti-phospholipid syndrome?

A

an acquired disorder characterised by a predisposition to both venous and arterial thromboses, recurrent fetal loss and thrombocytopenia

can be primary or secondary, commonly to SLE

antiphospholipid syndrome causes a paradoxical rise in the APTT

Lupus anticoagulant, anti-cardiolipin antibodies, beta-2 glycoprotein

105
Q

What is polymyalgia rheumatica?

A

relatively common condition seen in older people characterised by muscle stiffness and raised inflammatory markers

closely related to temporal arteritis

106
Q

Features of polymyalgia rheumatica?

A

Patient >60

Rapid onset (<1 month)

Aching, morning stiffness in proximal limb muscles - NOT weakness

Also mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, night sweats

107
Q

Investigations for polymyalgia reumatica?

A

raised inflammatory markers e.g. ESR > 40 mm/hr

note creatine kinase and EMG normal

108
Q

Treatment of polymyalgia reumatica?

A

prednisolone e.g. 15mg/od

patients typically respond dramatically to steroids, failure to do so should prompt consideration of an alternative diagnosis

109
Q

What is temporal arteritis?

A

large vessel vasculitis which overlaps with polymyalgia rheumatica (PMR)

Histology shows changes that characteristically ‘skips’ certain sections of the affected artery whilst damaging others

110
Q

Features of temporal arteritis?

A

Pt’s >60

Rapid onset (<1 month)

Headache

Jaw claudication

Visual disturbances - amaurosis fugal, blurring, double vision - secondary to anterior ischaemic optic neuropathy

Tender, palpable temporal artery

50% have features of PMR - aching, morning stiffness in proximal limb muscles

Lethargy, depression, low-grade fever, anorexia, night sweats

111
Q

Investigations for temporal arteritis?

A

raised inflammatory markers
ESR > 50 mm/hr (note ESR < 30 in 10% of patients)
CRP may also be elevated

temporal artery biopsy
skip lesions may be present

note creatine kinase and EMG normal

112
Q

Treatment of temporal arteritis?

A

urgent high-dose glucocorticoids should be given as soon as the diagnosis is suspected and before the temporal artery biopsy

  • if there is no visual loss then high-dose prednisolone is used
  • if there is evolving visual loss IV methylprednisolone

there should be a dramatic response with steroids, if not the diagnosis should be reconsidered

urgent ophthalmology review

bone protection with bisphosphonates is required as long, tapering course of steroids is required
low-dose aspirin is sometimes given to patients as well, although the evidence base supporting this is weak